India to Turkey Pharmaceutical Export (2026) — $161.4M, 287 Suppliers | TransData Nexus

India to Turkey Pharmaceutical Export (2026) — $161.4M, 287 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Turkey

#	Formulation	Value	Share
1	Ceftrorid 1g (ceftriaxone for Injection	$10.1M	6.2%
2	Abhayrab 0.5ml B.p	$5.3M	3.3%
3	Paracell (paracetamol Infusion 1000mg/10	$4.3M	2.7%
4	Isorid E	$4.3M	2.7%
5	Trastuzumab Lyophilized Powder for Injection (rdna Origin) 150 Mg[trastuzumab 1…	$3.7M	2.3%
6	Levorid E	$3.5M	2.2%
7	Mixed Vaccine for Mmr-viral Vaccine	$1.9M	1.2%
8	Azirid E	$1.9M	1.2%
9	Seroflo 250 Hfa Inhaler (salmeterol Xinafoate 25mcg+fluticasone Propionate 250m…	$1.5M	1.0%
10	Met Tara IV Metronidazole 500mg /100ml B	$1.5M	0.9%
11	Diphtheria and Tetanus Vaccine Adsorbed for Adults and Adolescents)1 Dose Vac	$1.4M	0.9%
12	Metrocell (metronidazole Infusion BP 500	$1.4M	0.8%
13	(mixed Vaccines for Diptheria and Tetanu	$1.3M	0.8%
14	Iburid (ibuprofen Oral Suspension BP 100	$1.3M	0.8%
15	Vomirid (ondansetron Injection BP 8mg/4m	$1.1M	0.7%

India exports 20+ pharmaceutical formulations to Turkey with a combined trade value of $161.4M. Key products include Ceftriaxone ($10.1M), Paracetamol ($4.3M), Trastuzumab ($3.7M), Levofloxacin ($3.5M), Vaccine ($1.9M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 15,362 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Turkey Trade Routes

1Ceftriaxone$10.1M

2Paracetamol$4.3M

3Trastuzumab$3.7M 4Levofloxacin$3.5M 5Vaccine

Top Indian Exporters to Turkey

1Medcell Pharma

$28.4M

2Serum Institute Of India Private Limited

$12.7M

3Indian Immunologicals Limited

$11.7M

4Kwality Pharmaceuticals Limited

$7.9M

Port Analysis — India to Turkey Pharmaceutical Shipments

Indian Export Ports

DHANDARI KALAN LUNDHIANA0.1%

SAHAR AIR CARGO ACC (INBOM4)23.6%

SAHAR AIR23.6%

NHAVA SHEVA SEA (INNSA1)9.9%

BANGALORE ACC (INBLR4)0.7%

Turkey Import Ports

Mersin16.1%

ISTANBUL39.7%

ANKARA2.2%

MERSIN8.5%

ADANA20.4%

Trade Statistics

Total Value$161.4M

Shipments15,362

Indian Exporters287

Turkey Buyers485

Avg Shipment$11K

Products10,591

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Turkey Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Turkey has experienced significant growth over the past decade. In 2024, India's pharmaceutical exports to Turkey reached $98.39 million, marking a substantial increase from previous years. This upward trajectory underscores the strengthening economic ties and the growing demand for Indian pharmaceutical products in the Turkish market.

Key milestones in this bilateral trade include the establishment of direct shipping routes and the initiation of joint ventures between Indian pharmaceutical companies and Turkish distributors. These collaborations have facilitated smoother logistics and enhanced market penetration. The consistent growth in export value reflects the successful adaptation of Indian pharmaceutical firms to the regulatory and market dynamics of Turkey.

2India's Market Position

India holds a significant share in Turkey's pharmaceutical import market, positioning itself as a key supplier alongside other origins. The strategic importance of this relationship is evident in the diversification of India's export portfolio, which includes a range of generic and branded formulations tailored to meet Turkey's healthcare needs. This market presence is bolstered by India's competitive pricing and the high quality of its pharmaceutical products.

Recent Developments

Turkey Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Turkey must adhere to the guidelines set by the Turkish Medicines and Medical Devices Agency. The registration process involves submitting a comprehensive dossier that includes toxicological and pharmacological tests, clinical trial data, and a description of control methods used by the manufacturer. The dossier must be prepared in the Common Technical Document (CTD) format, which is internationally recognized. The timeline for registration can vary, but it typically spans several months, depending on the complexity of the product and the completeness of the submitted documentation.

2GMP & Facility Requirements

Turkey requires that manufacturing sites comply with Good Manufacturing Practices (GMP) standards to ensure the quality and safety of pharmaceutical products. The inspection process involves a thorough evaluation of the manufacturing facilities, including assessments of production processes, quality control measures, and documentation practices. Mutual recognition agreements between Turkey and other countries may facilitate the acceptance of GMP certifications, but Indian manufacturers should verify the specific requirements and agreements in place to streamline the approval process.

3Import Documentation

To import pharmaceutical products into Turkey, companies must obtain an import license from the Ministry of Health. This license is granted based on a market authorization, which is typically held by the Turkish subsidiary of the pharmaceutical manufacturer. The import documentation includes a commercial invoice, bill of lading or airway bill, packing list, certificate of origin, and a certificate of analysis. Additionally, a certificate of control from the Ministry of Health is required, which involves submitting documents such as a pro forma invoice, certificate of analysis, and an approved health certificate issued by the competent authority in the country of origin.

EXPORT_TRENDS

TransData Nexus Research · Turkey regulatory databasesMar 2026

FAQ — India to Turkey Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Turkey?

India exported pharmaceuticals worth $161.4M to Turkey across 15,362 verified shipments.

Who are the top Indian pharmaceutical exporters to Turkey?

1. MEDCELL PHARMA — $28.4M. 2. SERUM INSTITUTE OF INDIA PRIVATE LIMITED — $12.7M. 3. INDIAN IMMUNOLOGICALS LIMITED — $11.7M. Total: 287 suppliers.

Which companies in Turkey import pharmaceuticals from India?

1. SEA GOLD PHARMA — $22.2M. 2. CENTURION ILAC SANAYI VE TICARET AN — $9.4M. 3. ABDI IBRAHIM ILAC SANAYI VE TICARET — $8.1M. 485 buyers total.

What pharmaceutical products does India export most to Turkey?

1. Ceftrorid 1g (ceftriaxone for Injection ($10.1M, 6.2%); 2. Abhayrab 0.5ml B.p ($5.3M, 3.3%); 3. Paracell (paracetamol Infusion 1000mg/10 ($4.3M, 2.7%); 4. Isorid E ($4.3M, 2.7%); 5. Trastuzumab Lyophilized Powder for Injection (rdna Origin) 150 Mg[trastuzumab 1… ($3.7M, 2.3%)

Which ports handle pharmaceutical shipments from India to Turkey?

Export: DHANDARI KALAN LUNDHIANA, SAHAR AIR CARGO ACC (INBOM4), SAHAR AIR, NHAVA SHEVA SEA (INNSA1), BANGALORE ACC (INBLR4). Import: Mersin, ISTANBUL, ANKARA, MERSIN, ADANA.

Why does Turkey import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $161.4M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Turkey?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Turkey pharmaceutical trade?

$10.5K per consignment across 15,362 shipments.

How many Indian pharmaceutical companies export to Turkey?

287 Indian companies. Largest: MEDCELL PHARMA with $28.4M.

How can I find verified Indian pharmaceutical suppliers for Turkey?

TransData Nexus covers 287 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Turkey identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 15,362 verified shipments from 287 Indian exporters to 485 Turkey buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

287 Exporters

485 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Turkey Pharmaceutical Export

Top Pharmaceutical Formulations — India to Turkey

Top Pharmaceutical Products — India to Turkey Trade Routes

Top Indian Exporters to Turkey

Port Analysis — India to Turkey Pharmaceutical Shipments

Indian Export Ports

Turkey Import Ports

Trade Statistics

Other Destinations

India–Turkey Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Recent Developments

Top Turkey Buyers from India

Product Routes

Full Dataset Access

Turkey Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Turkey

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Turkey

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Turkey Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Turkey for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters